Subscribe To
Prime medicine reports third quarter 2023 financial results and provides business updates
— Presented new preclinical research across multiple programs, including proof-of-concept data from in vivo rodent and large animal studies, as well...
November 3, 2023, 8:01 pm
Acumen pharmaceuticals presents late-breaker phase 1 updates exploring novel target engagement, dosing regimen and safety findings for acu193 in early alzheimer’s disease at the 16th annual clinical t
– Acumen presented data exploring target engagement modeling of ACU193, the first clinical-stage amyloid beta oligomer (AβO)-targeting antibody, to...
October 27, 2023, 1:25 pm
Surfing the waves with gregor horvat – elliott wave analysis
In today’s advanced Elliott Wave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
October 25, 2023, 10:52 am
Moderna and caris life sciences partner to develop mrna oncology therapeutics
Moderna Therapeutics Inc (NASDAQ:MRNA) has teamed up with Texas-headquartered private precision medicine and molecular science firm Caris Life Science...
October 24, 2023, 10:21 am
United therapeutics: both fundamental and technical analyses justify a buy decision
United Therapeutics Corporation is in a long-term uptrend, reaching a new all-time high, indicating strong demand for the stock. The company has a com...
October 22, 2023, 12:25 pm
Calliditas therapeutics to present seven abstracts at the american society of nephrology (asn) kidney week 2023
STOCKHOLM , Oct. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas"), today announced seven ab...
October 19, 2023, 3:58 am
Surfing the waves with gregor horvat – elliott wave analysis
In today’s advanced Elliott Wave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
October 18, 2023, 9:37 am
Abb ceo: europe weakest region across business
Björn Rosengren, CEO of ABB, discusses third-quarter earnings and analyses demand across China, Europe...
October 18, 2023, 3:57 am
Iphone 15 sales trail predecessor in china
Chinese consumers are reportedly less enthusiastic about the iPhone 15 than the iPhone 14. Separate analyses...
October 16, 2023, 4:07 pm
Merck to present latest research from oncology portfolio at esmo 2023
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research ...
October 16, 2023, 2:00 am
Eur/usd forecast: us dollar rises amid middle east concerns; german production eyed
Shifting EUR/USD dynamics underscore Middle East unrest and pivotal ECB, FOMC analyses. The post EUR/US...
October 9, 2023, 5:30 am
Aud/usd forecast: will the australian dollar continue to decline in 2023?
Explore the most recent predictions for AUD/USD in 2023-2024. Dive into technical and fundamental analyses...
October 6, 2023, 11:55 am
Japanese yen outlook: usd/jpy in calm waters for now but bullish breakout looms
This article focuses on USD/JPY’s near-term outlook, incorporating both fundamental and technical analyses...
October 4, 2023, 7:35 pm
Verona pharma to present additional analyses of positive phase 3 enhance studies in copd at chest 2023
PDUFA Target Action Date of June 26, 2024 Pooled analysis and subgroup data further support potential of ensifentrine, an investigational, novel, se...
October 3, 2023, 2:00 am
Eur/usd forecast: is recession looming? pmis and powell take center stage
With EUR/USD experiencing fluctuations, eyes are on Eurozone PMIs and Powell’s outlook, potentially redefining forecast ...
October 2, 2023, 5:44 am
Surfing the waves with gregor horvat – elliott wave analysis
In today’s advanced Elliott Wave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
September 28, 2023, 11:35 am
Surfing the waves with gregor horvat – elliott wave analysis
In today’s advanced Elliott Wave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
September 19, 2023, 10:44 am
Brainstorm cell therapeutics: i anticipate a positive adcom but there are major risks
BCLI has completed a phase 3 trial in ALS. Despite not meeting the primary endpoint BCLI is still applying for approval and an AdCom meeting is schedu...
September 15, 2023, 6:03 pm
Surfing the waves with gregor horvat – elliott wave analysis
In today’s advanced Elliott Wave analysis, Gregor dives into the five most interesting opportunities for the week ahead! Watch how he ...
September 13, 2023, 10:14 am
Boe mann: risk of tightening too little more salient
BoE MPC member Catherine Mann expressed a potent concern regarding the UK’s current economic landscape, emphasizing the “salient” risk of “tig...
September 11, 2023, 2:26 pm